Eden Research (LON:EDEN) Stock Price Up 10.5% – Still a Buy?

Eden Research plc (LON:EDEN) shares shot up 10.5% during mid-day trading on Friday. The company traded as high as GBX 3.90 and last traded at GBX 3.43. 6,729,103 shares were traded during trading, an increase of 988% from the average session volume of 618,734 shares. The stock had previously closed at GBX 3.10.

Eden Research Stock Performance

The stock has a market cap of £27.52 million, a PE ratio of -7.73 and a beta of 1.55. The company has a quick ratio of 2.42, a current ratio of 1.95 and a debt-to-equity ratio of 5.41. The firm has a 50 day moving average price of GBX 2.53 and a 200 day moving average price of GBX 3.01.

Eden Research (LON:EDEN) last released its quarterly earnings data on Wednesday, August 26th. The company reported GBX (0.36) earnings per share for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. As a group, research analysts forecast that Eden Research plc will post -66.00 earnings per share for the current year.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.